THE LOW CARB DIABETIC

Would you like to react to this message? Create an account in a few clicks or log in to continue.
THE LOW CARB DIABETIC

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

2 posters

    Open-Data Momentum Builds; Trialist Resistance May Be Futile

    graham64
    graham64
    Member


    Status :
    Online
    Offline

    Male Posts : 3730
    Join date : 2014-08-10
    Location : Lancs

    Open-Data Momentum Builds; Trialist Resistance May Be Futile Empty Open-Data Momentum Builds; Trialist Resistance May Be Futile

    Post by graham64 Fri Apr 21 2017, 22:38

    Background

    In early April, the New England Journal of Medicine (NEJM) held a 1.5-day event in Boston called "Aligning Incentives for Sharing Clinical Trial Data" which was broadcast on the Web. Panels featured clinical trialists, data analysts, and patient participants—the three groups with interests in data—as well as government and funding agencies. To explore the potential benefits of data sharing ahead of the event, NEJM launched the SPRINT Data Analysis Challenge. The National Institutes of Health (NIH)- sponsored SPRINT trial compared intensive (≤120 mm Hg) versus standard blood pressure control in hypertensive patients at high cardiovascular risk. Challenge entrants were invited to analyze the dataset underlying the main publication and identify a novel finding that advances medical science. The three winners presented on day one of the webinar.
    Watching the data summit online and following the Twittersphere (#NEJMDataSummit storified), data analysts and trial participants came across as open-data evangelicals, while clinical trialists who expressed concerns about misuse of data and lost career opportunities seemed like the "get off my lawn" old guard. Most trialists were not against the concept of data sharing but wanted an extended period of exclusive access and gatekeepers to control who got access as opposed to a more liberal free-for-all.

    Medscape asked some attendees for feedback. Open-data proponent Atul Butte, MD, PhD (UCSF) emailed that he was optimistic and "saw a lot of change in attitudes during the summit." However, research-participant representative Sharon Terry (CEO, Genetic Alliance), who has two children with a rare disease, was "not surprised by the paternalistic, protectionist, conservative stance of the trialists" and "did not sense any transformation in their thinking."

    More here http://www.medscape.com/viewarticle/878670
    chris c
    chris c
    Member


    Status :
    Online
    Offline

    Posts : 4520
    Join date : 2015-07-26

    Open-Data Momentum Builds; Trialist Resistance May Be Futile Empty Re: Open-Data Momentum Builds; Trialist Resistance May Be Futile

    Post by chris c Fri Apr 21 2017, 23:41

    Hehe, Lord God Sir Professor Rory Collins came across just like T Colon Campbell after Denise Minger dissected his China Study magnum opus.
    graham64
    graham64
    Member


    Status :
    Online
    Offline

    Male Posts : 3730
    Join date : 2014-08-10
    Location : Lancs

    Open-Data Momentum Builds; Trialist Resistance May Be Futile Empty Re: Open-Data Momentum Builds; Trialist Resistance May Be Futile

    Post by graham64 Sat Apr 22 2017, 23:41

    chris c wrote:Hehe, Lord God Sir Professor Rory Collins came across just like T Colon Campbell after Denise Minger dissected his China Study magnum opus.

    Very much doubt Sir Rory Statin will come clean with the data from his studies see MK's take on him

    https://drmalcolmkendrick.org/2015/02/16/a-humiliating-climb-down-or-a-machiavellian-move/

    Sponsored content


    Open-Data Momentum Builds; Trialist Resistance May Be Futile Empty Re: Open-Data Momentum Builds; Trialist Resistance May Be Futile

    Post by Sponsored content


      Current date/time is Fri Mar 29 2024, 01:53